Gilead Sciences (NASDAQ: GILD) scored a win against alleged counterfeiters as a federal judge in New York ordered the freezing of assets of different people and entities accused of distributing counterfeit bottles of the biopharmaceutical company's HIV drugs, Reuters reported on Thursday. The report stated that according to court filings, Gilead has been pursuing these counterfeiters and has unearthed a massive nationwide operation "staggering in scope" which is responsible for selling millions of dollars worth of counterfeit bottles of its top sellers Descovy, Genvoya, and Biktarvy. Reuters stated that HIV drugs made up around 60% of Gilead's $12.6 billion revenue in the year's first half.
https://www.tipranks.com/news/gilead-nasdaq-gild-ups-the-ante-against-counterfeit-hiv-drug-ring?utm_source=advfn.com&utm_medium=referral
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Gilead Sciences Charts.
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Gilead Sciences Charts.